Featured
-
Testosterone Replacement in Men With Prostate Cancer
Is testosterone replacement in men with prostate cancer safe? -
Canagliflozin Lowers ESRD Risk in Diabetic Kidney Disease
In a study of patients with type 2 diabetes and chronic kidney disease, canagliflozin, an SGLT2 inhibitor, decreased the risk of end-stage renal disease by 32% compared with placebo. -
Darolutamide Granted Priority Review Status for nmCRPC
FDA has accepted a New Drug Application and granted Priority Review for darolutamide for the treatment of nonmetastatic castration-resistant prostate cancer. -
IgA Nephropathy Shortens Life Expectancy
In a study, IgA nephropathy patients lived a median 6 fewer years than age-matched controls without the disease. -
Potassium Additives a Concern for Hyperkalemia Patients
Hyperkalemia management is hindered by the shortage of information about potassium additives in foods, according to the author of new review. -
UTUC Recurrence Risk Lowered With Adjuvant Chemotherapy
Adjuvant chemotherapy given to patients following underwent radical surgery for locally advanced upper tract urothelial carcinoma was associated with a significantly decreased risk of tumor recurrence. -
Threat Analyses, Security Gap Remediation Key to HIPAA Compliance
In a recent press release, the federal Office for Civil Rights (OCR) announced it concluded 2018 with a record of $28.7 million from the settlement of 10 cases and the winning of a judgment in another regarding HIPAA compliance violations. The amount was 22% greater than its previous high of $23.5 million in 2016. These… -
Embrace, Don’t Fear, Price Transparency
Letting patients know the prices of health care services in advance can increase practice income and engender patient loyalty. -
Responding to Patients’ Discriminatory Comments
Health care professionals have the right to protect themselves from unjust discrimination, but doing so should not interfere with their professional commitments to promote patient’s access to care, even when patients exhibit objectionable behavior.
Latest Nephrology News
Fournier Gangrene Is Safety Concern With SGLT2 Inhibitors
Post-Nephrectomy AKI Harms Long-Term Renal Functional Recovery
Adverse Childhood Experiences Linked to Worse Lupus Outcomes
Latest Urology News
Bavencio Plus Inlyta Approved as First-Line Tx for Advanced Renal Cell Carcinoma
BPH Meds Found to Delay Prostate Cancer Diagnosis
